S. 3014

119th CongressIn committee

Ensuring Timely Access to Generics Act of 2025

Sponsored by Jeanne Shaheen (Democrat-NH)

Healthcare Costs & Access Healthcare & Public Health Medicare & Medicaid Pharmaceutical Policy

Cosponsors

Actions

Roll calls

Amendments

Related bills

Actions

Oct 16, 2025 · Library of Congress

Introduced in Senate

Oct 16, 2025 · Senate

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Latest activity

Activity

July 2026

Lobbying reported · Biotechnology Innovation Organization · Jul 21

Biotechnology Innovation Organization reported 2nd Quarter (Apr 1 - June 30) lobbying for Biotechnology Innovation Organization — $2,360,000

Lobbying reported · Covington & Burling · Jul 20

Covington & Burling reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research Manufacturers Of America — $220,000

BillsH.R. 2715 H.R. 5526 H.R. 7953 H.R. 8646 S. 1954 S. 2658 S. 3014

Lobbying reported · America's Health Insurance Plans (ahip) · Jul 20

America's Health Insurance Plans (ahip) reported 2nd Quarter (Apr 1 - June 30) lobbying for America's Health Insurance Plans (ahip) — $3,010,000

BillsH.R. 1 H.R. 247 H.R. 379 H.R. 584 H.R. 608 H.R. 610 H.R. 842 H.R. 935 H.R. 950 H.R. 957 H.R. 1096 H.R. 1117 H.R. 1157 H.R. 1162 H.R. 1397 H.R. 1403 H.R. 1523 H.R. 1614 H.R. 1627 H.R. 1775 H.R. 1776 H.R. 1805 H.R. 1867 H.R. 1899 H.R. 1924 H.R. 2013 H.R. 2045 H.R. 2049 H.R. 2079 H.R. 2199 H.R. 2309 H.R. 2433 H.R. 2450 H.R. 2528 H.R. 2533 H.R. 2553 H.R. 2554 H.R. 2571 H.R. 2586 H.R. 2610 H.R. 2636 H.R. 2741 H.R. 3000 H.R. 3023 H.R. 3069 H.R. 3415 H.R. 3493 H.R. 3527 H.R. 3546 H.R. 3701 H.R. 3789 H.R. 3808 H.R. 4093 H.R. 4206 H.R. 4231 H.R. 4313 H.R. 4317 H.R. 4406 H.R. 4559 H.R. 4605 H.R. 4623 H.R. 4641 H.R. 4710 H.R. 5081 H.R. 5145 H.R. 5243 H.R. 5281 H.R. 5371 H.R. 5509 H.R. 5526 H.R. 5582 H.R. 5584 H.R. 6010 H.R. 6232 H.R. 6248 H.R. 6255 H.R. 6361 H.R. 6703 H.R. 6951 H.R. 6974 H.R. 7023 H.R. 7064 H.R. 7164 H.R. 7189 H.R. 7409 H.R. 7537 H.R. 7727 H.R. 7778 H.R. 7787 H.R. 7790 H.R. 7803 H.R. 7837 H.R. 7871 H.R. 8270 H.R. 8375 H.R. 8377 H.R. 8684 H.R. 8779 H.R. 8875 H.R. 9393 H.R. 9504 S. 339 S. 483 S. 526 S. 529 S. 652 S. 717 S. 729 S. 752 S. 864 S. 882 S. 891 S. 931 S. 939 S. 976 S. 1040 S. 1056 S. 1082 S. 1096 S. 1227 S. 1261 S. 1637 S. 1753 S. 1816 S. 1818 S. 1847 S. 1954 S. 1973 S. 2237 S. 2289 S. 2345 S. 2355 S. 2356 S. 2497 S. 2556 S. 2620 S. 2658 S. 2709 S. 2903 S. 3014 S. 3599 S. 3642 S. 3690 S. 3727 S. 3729 S. 3750 S. 3751 S. 3762 S. 3822 S. 3829 S. 3834 S. 3848 S. 3886 S. 3990 S. 4189 S. 4332 S. 4355 S. 4384 S. 4509 S. 4512

Lobbying reported · Kaiser Foundation Health Plan · Jul 20

Kaiser Foundation Health Plan reported 2nd Quarter (Apr 1 - June 30) lobbying for Kaiser Foundation Health Plan — $530,000

BillsH.R. 3269 H.R. 3514 H.R. 5429 H.R. 5526 H.R. 5582 H.R. 6248 H.R. 6644 H.R. 7148 H.R. 8800 H.R. 9393 H.R. 9504 S. 43 S. 1816 S. 1954 S. 2355 S. 2620 S. 2780 S. 3014 S. 3822 S. 4027 S. 4784

Lobbying reported · The Nickles Group · Jul 20

The Nickles Group reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $60,000

BillsH.R. 1 S. 1954 S. 2658 S. 3014 S. 3788

Lobbying reported · Blue Cross And Blue Shield Of Florida · Jul 20

Blue Cross And Blue Shield Of Florida reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Of Florida — $80,000

Lobbying reported · Blood Cancer United · Jul 20

Blood Cancer United reported 2nd Quarter (Apr 1 - June 30) lobbying for Blood Cancer United — $590,000

Lobbying reported · Amgen · Jul 20

Amgen reported 2nd Quarter (Apr 1 - June 30) lobbying for Amgen — $2,440,000

Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20

Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000

Lobbying reported · Small Business & Entrepreneurship Council (SBE Council) · Jul 20

Small Business & Entrepreneurship Council (SBE Council) reported 2nd Quarter (Apr 1 - June 30) lobbying for Small Business & Entrepreneurship Council (SBE Council) — $45,000

Lobbying reported · The Institute For Family Health · Jul 20

The Institute For Family Health reported 2nd Quarter (Apr 1 - June 30) lobbying for American Association Of Teaching Health Centers — $25,000

BillsS. 3014

Lobbying reported · American Society Of Health-System Pharmacists · Jul 20

American Society Of Health-System Pharmacists reported 2nd Quarter (Apr 1 - June 30) lobbying for American Society Of Health-System Pharmacists — $260,000

Lobbying reported · Blue Cross And Blue Shield Association · Jul 20

Blue Cross And Blue Shield Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Association — $990,000

Lobbying reported · Fierce Government Relations · Jul 20

Fierce Government Relations reported 2nd Quarter (Apr 1 - June 30) lobbying for Association Of Accessible Medicines — $60,000

BillsH.R. 7410 S. 1954 S. 2658 S. 3014 S. 3788 S. 4327 S. 4784

Lobbying reported · Guidewell Mutual Holding · Jul 20

Guidewell Mutual Holding reported 2nd Quarter (Apr 1 - June 30) lobbying for Guidewell Mutual Holding — $20,000

Lobbying reported · Blue Cross Blue Shield Of Michigan · Jul 20

Blue Cross Blue Shield Of Michigan reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross Blue Shield Of Michigan — $276,347

Lobbying reported · Bluecross Blueshield Of Tennessee · Jul 18

Bluecross Blueshield Of Tennessee reported 2nd Quarter (Apr 1 - June 30) lobbying for Bluecross Blueshield Of Tennessee — $140,000

BillsH.R. 842 H.R. 2079 H.R. 3514 H.R. 4570 H.R. 4710 H.R. 6248 H.R. 8684 H.R. 8871 H.R. 9393 S. 1040 S. 1096 S. 2355 S. 3014 S. 3762 S. 4027

Lobbying reported · Crossroads Strategies · Jul 18

Crossroads Strategies reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $50,000

BillsH.R. 1492 H.R. 8646 H.R. 8800 H.R. 9260 S. 527 S. 832 S. 891 S. 1040 S. 1096 S. 2658 S. 3014 S. 4784

Lobbying reported · Bcbsm · Jul 17

Bcbsm reported 2nd Quarter (Apr 1 - June 30) lobbying for Bcbsm — $28,000

BillsH.R. 1 H.R. 1197 H.R. 1627 H.R. 1843 H.R. 1909 H.R. 2509 H.R. 3841 H.R. 4570 H.R. 4710 H.R. 5629 H.R. 6248 S. 931 S. 958 S. 1040 S. 1096 S. 1302 S. 1954 S. 2355 S. 2658 S. 3014 S. 4027

Lobbying reported · Glaxosmithkline · Jul 16

Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000